Financial Data and Key Metrics Changes - New Health reported adjusted EBITDA of $19 million for Q2 2025, contributing to a total of $32.5 million for the first half of the year, indicating continued profitability [5][13] - Consolidated revenue for Q2 was $209.1 million, slightly lower than the prior year due to a shift in membership mix [13] - Gross margin for Q2 was $62.7 million, maintaining adjusted EBITDA profitability for the sixth consecutive quarter [13] Business Line Data and Key Metrics Changes - In the New Care segment, revenue was $91.6 million with an operating income of $23.2 million, serving 504,000 value-based consumers [14][15] - The New Solutions segment generated $120 million in revenue with an operating income of $2.6 million, serving 148,000 consumers in the Provider Enablement business [15] - Overall, the company served 694,000 consumers in Q2, reflecting a 45% increase compared to the same quarter last year [14] Market Data and Key Metrics Changes - The ACA marketplace segment served 485,000 consumers, performing better than the market in terms of medical loss ratio [7] - The Senior Care business served 65,000 consumers across Medicare Advantage, ACO REACH, and MSSP [8] - Medicaid consumers served totaled 144,000, primarily in the provider enablement business [9] Company Strategy and Development Direction - The company is focused on a consumer-centric care model that aligns the interests of consumers, payers, and providers, supporting the shift to value-based care [6] - New Health is advancing its data and analytics capabilities through a platform called NewPulse, aimed at integrating care delivery solutions and administrative functions [10][11] - The company is expanding partnerships with Walgreens to enhance access to care through in-store clinics [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's market position and the ability to deliver value through coordinated care experiences [17] - The company anticipates closing a transaction to go private in mid to late 2025, pending necessary conditions [12] - Management is optimistic about building on successes and continuing momentum for the remainder of 2025 and beyond [17] Other Important Information - The company emphasizes the importance of preventative care and community engagement, as demonstrated by partnerships for mobile mammogram screenings [8] - NewPulse is expected to eliminate the need for pre-authorizations and align financing with care delivery [11] Q&A Session Summary - No specific questions or answers were documented in the provided content.

Privia Health Group (PRVA) Q1 2025 Earnings Call May 08, 2025 08:00 AM ET Company Participants Robert Borchert - SVP, Investor and Corporate CommunicationsParth Mehrotra - CEODavid Mountcastle - EVP & CFOJailendra Singh - Managing DirectorJoshua Raskin - Partner - Managed Care & ProvidersRichard Close - Managing DirectorAlberta Massey - Equity Research AssociateA.J. Rice - Managing DirectorThomas Walsh - Equity Research AssociateConstantine Davides - Managing DirectorJack Slevin - VP - Healthcare Services E ...